Wow, the CEO of AIM Immunotech takes LC and ME/CFS very seriously. They're clearly devoted to testing Ampligen in LC because they see it as a major potential market.
I'm still baffled that pharmaceutical companies don't see it: chronic illness is a gold mine. It's the rarest combination of issues where you can provide a complete cure for something, and keep selling it anyway. Because it keeps getting created all the time. You could cure everyone with a chronic illness today and a year from now there will be millions. As long as common infections are a part of normal life, there will always be people with this type of illness.
Even if someone is "only" ill for 3 months, it's worth it to them. Hell, it's worth it for 3 days, this is why cold/flu medication are such a big market. No one likes being ill, contrary to the absurd belief system in medicine. People will pay significant sums to simply cut the illness short, and no one knows if they're in it for a few days, weeks, or years. And medicine sure doesn't know any better about it. If the treatments are afforable, everyone would buy them. Always. Every time.
It's a far better market than antidepressant and the like, since you don't even have to get people to keep using the drugs. There are constantly new people falling ill, it just never ends. It will probably never end, not until we reach the stage where immune systems can be complemented with advanced technology, and by then we'd be so technologically advanced that most current drugs and treatments will be obsolete anyway.
